secwatch.observer — SEC 8-K summary
======================================

Issuer:     Kura Oncology, Inc. (KURA)
CIK:        0001422143
Form:       8-K
Filed at:   2025-01-14T23:59:59+00:00
Accession:  0001193125-25-006197
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 2.03
LLM model:  deepseek-v4-flash:cloud@v2

Kura Oncology enters lease for new San Diego headquarters, 32,512 sq ft
-----------------------------------------------------------------------

- Lease of 32,512 sq ft at 4930 Directors Place, San Diego, for new principal executive offices and R&D.
- Term 7 years 8 months, one 5-year extension option; monthly rent ~$183,693 first year, 3% annual increases.
- Rent abatement up to $2.4M and tenant improvement allowance up to $6.2M.
- Early termination right after 5.5 years with 12 months notice and 8 months rent penalty.
- Obligation includes base rent and additional rent for operating expenses, taxes, utilities.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1422143/000119312525006197/0001193125-25-006197-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1422143/000119312525006197/d875953d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-006197

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer